Breaking News Instant updates and real-time market news.

MMM

3M

$166.26

-2.81 (-1.66%)

, AXP

American Express

$119.86

0.86 (0.72%)

04:55
05/21/19
05/21
04:55
05/21/19
04:55

Expereint to host a conference

National Restaurant Association Show 2019 will be held in Chicago on May 18-21.

MMM

3M

$166.26

-2.81 (-1.66%)

AXP

American Express

$119.86

0.86 (0.72%)

T

AT&T

$32.19

0.4 (1.26%)

AVY

Avery Dennison

$99.88

-1.78 (-1.75%)

BMS

acquired by AMCR

$57.94

-0.03 (-0.05%)

CAG

Conagra Brands

$28.49

-0.59 (-2.03%)

FDP

Fresh Del Monte

$28.52

-0.73 (-2.50%)

DGII

Digi International

$11.88

-0.06 (-0.50%)

ECL

Ecolab

$181.10

-0.42 (-0.23%)

FDC

First Data

$25.87

-0.13 (-0.50%)

HRL

Hormel Foods

$39.71

-0.05 (-0.13%)

LCUT

Lifetime Brands

$9.20

-0.38 (-3.97%)

MA

MasterCard

$253.54

1.06 (0.42%)

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 28

    May

  • 29

    May

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 25

    Jun

  • 24

    Jul

  • 13

    Nov

MMM 3M
$166.26

-2.81 (-1.66%)

05/17/19
JPMS
05/17/19
NO CHANGE
Target $143
JPMS
Underweight
3M price target lowered to $143 from $154 at JPMorgan
JPMorgan analyst Stephen Tusa lowered his price target for 3M to $143 from $154 after cutting his estimates to a Street low. Estimates for 3M "are far from reset, further laid bare by a cut to the buyback," Tusa tells investors in a research note. The analyst sees "neither defense, nor growth" at the company and maintains an Underweight rating on the shares. He points out that 3M's guidance calls for a second-half acceleration and that the company faces "record high inventories not seen in the 15 years of data."
04/29/19
04/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lionsgate (LGF, LGF.A, LGF.B) downgraded to In-Line from Outperform at Imperial Capital with analyst David Miller citing additional promotional expenses related to the Starz international rollout. 2. Occidental Petroleum (OXY) downgraded to Hold from Buy at Jefferies with analyst Jason Gammel saying the company's hostile counter-offer for Anadarko (APC) is a "risky but perhaps necessary move against a better-capitalized bidder for a company that rejected its initial overtures." 3. CVS Health (CVS) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying the stock faces a transitional year as it tries to drive seismic changes in healthcare. 4. Intel (INTC) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the company's Q1 earnings miss and reduced FY19 outlook that reflected the company's Data Center Group weakness, which he calls "the linchpin of growth." 5. 3M (MMM) downgraded to Hold from Buy at Gordon Haskett with analyst John Inch downgraded saying his concerns extend beyond the company's Q1 earnings miss and steep guidance reduction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/29/19
GDHS
04/29/19
DOWNGRADE
GDHS
Hold
3M downgraded to Hold from Buy at Gordon Haskett
04/29/19
GDHS
04/29/19
DOWNGRADE
Target $185
GDHS
Hold
Gordon Haskett downgrades 3M to Hold on execution concerns
As previously reported, Gordon Haskett analyst John Inch downgraded 3M to Hold from Buy, stating that his concerns extend beyond the company's Q1 earnings miss and steep guidance reduction. Self-help benefits that have been years in the making "have largely evaporated," while the "outsized decremental operating profit realized in the first quarter begs the question whether years of 3M footprint rationalization have actually made things worse," Inch tells investors in his downgrade note. 3M's response of cutting about 2% of the company's workforce doesn't seem "all that aggressive," added Inch, who wonders if it in fact may be an insufficient response. He lowered his price target on 3M shares to $185 from $222.
AXP American Express
$119.86

0.86 (0.72%)

05/15/19
RHCO
05/15/19
NO CHANGE
Target $14
RHCO
Buy
Green Sky's loss of Regions as funding partner 'not material,' says SunTrust
After Green Sky (GSKY) disclosed in a 10Q this morning that it has lost Regions Financial (RF) as a funding partner for its indirect lending product, SunTrust analyst Andrew Jeffrey said the news is "clearly a negative," as Regions is about 17% of the company's total max funding commitment, he does not believe this loss alone will constrain the calendar 2019 revenue growth outlook. Based on the 10Q, less than $150M of the funding commitment was unused, and therefore, Jeffrey contends that it is likely not material to the $4.5B in total funding the company highlighted on its recent conference call. Jeffrey, who has a Buy rating and $14 price target on Green Sky shares, says he "likes" the company's competitive position, value proposition, potential upside from new Healthcare offerings and the new American Express (AXP) relationship.
04/29/19
04/29/19
DOWNGRADE
Target $118

Neutral
American Express downgraded to Neutral at UBS on limited earnings upside
As previously reported, UBS analyst Eric Wasserstrom downgraded American Express to Neutral but raised his price target to $118 from $113. The analyst notes that in spite of the company's "steady performance", he no longer sees "significant upside to consensus EPS forecasts". Wasserstrom adds that the current valuation on American Express of 14.7-times forward earnings is close to one standard deviation from its longer term average of 13.3-times and also warns about the company's "rising credit losses."
05/03/19
RBCM
05/03/19
INITIATION
Target $120
RBCM
Sector Perform
American Express assumed with a Sector Perform at RBC Capital
RBC Capital analyst Jon Arfstrom assumed coverage of American Express with a Sector Perform rating and a price target of $120, saying the stock is a "high quality core holding" give n the company's unique card network model and a history of industry leading returns. The analyst also points to the "strong premium" brand of American Express which should make the company's performance "relatively resilient" in the event of an economic slowdown.
05/20/19
SPHN
05/20/19
NO CHANGE
Target $131
SPHN
Overweight
Stephens sees significant growth opportunity for AmEx in B2B payments
Stephens analyst Vincent Caintic, after hosting meetings with American Express management, said that he sees a significant opportunity for the company in the Business-To-Business, or B2B, space, particularly in payments to suppliers. The biggest challenge is signing suppliers to take American Express as a form of payment, but the company's current key value proposition is paying suppliers faster for accepting the card, Caintic explains. He keeps an Overweight rating and $131 price target on AmEx shares following the management meetings.
T AT&T
$32.19

0.4 (1.26%)

05/15/19
JPMS
05/15/19
NO CHANGE
Target $67
JPMS
Neutral
Amdocs price target lowered to $67 from $70 at JPMorgan
JPMorgan analyst Jackson Ader lowered his price target for Amdocs (DOX) to $67 from $70 saying that while the company's fiscal Q2 results were better than expected, the commentary on AT&T (T) is the main takeaway. AT&T revenue is off to a worse start for the first half than the company had expected as the focus on cost cutting and debt reduction within AT&T continues, Ader tells investors in a research note. The analyst does not see "this AT&T headwind going anywhere" and he keeps a Neutral rating on Amdocs.
05/09/19
SBSH
05/09/19
UPGRADE
SBSH
Neutral
CenturyLink upgraded to Neutral on cash flow, cost cutting at Citi
As previously reported, Citi analyst Michael Rollins upgraded CenturyLink (CTL) to Neutral from Sell. While he said the company reported "another mixed quarter" and he thinks the pace of revenue decline should continue to depress the multiple, the company's "aggressive" cost cutting, cash flow and dividend yield should provide downside support, Rollins tells investors. He remains cautious on whether CenturyLink can create value by separating its consumer business, he added. Rollins recommends that investors seeking dividends in Telco buy AT&T (T) and Verizon (VZ) instead.
05/03/19
NRCS
05/03/19
UPGRADE
Target $70
NRCS
Buy
Northcoast upgrades Generac to Buy as emerging play on 5G growth
As previously reported, Northcoast analyst Tom Hayes upgraded Generac to Buy from Neutral as he sees significant benefits from its increased closing rates for home standby units and the backup power needs associated with 5G growth. Spending for the infrastructure for 5G is expected to ramp to $26B in 2022 and Generac has established relationships with Verizon (VZ), AT&T (T) and T-Mobile (TMUS), noted Hayes, who believes the company is likely used by the major carriers in a significant percentage of all their back-up power needs. He set a $70 price target on Generac shares.
04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).
AVY Avery Dennison
$99.88

-1.78 (-1.75%)

04/08/19
04/08/19
DOWNGRADE

Sector Weight
Avery Dennison downgraded to Sector Weight on valuation at KeyBanc
As previously reported, KeyBanc analyst Adam Josephson downgraded Avery Dennison to Sector Weight from Outperform after the stock exceeded his previous price target of $110, and as he sees limited upside from here. While the analyst remains "quite comfortable" with Avery Dennison's long-term fundamentals compared to the broader packaging group, he thinks slowing global economic growth and its FX translation exposure will limit further share price upside from here.
04/08/19
KEYB
04/08/19
DOWNGRADE
KEYB
Sector Weight
Avery Dennison downgraded to Sector Weight from Overweight at KeyBanc
04/18/19
JPMS
04/18/19
DOWNGRADE
Target $105
JPMS
Underweight
Avery Dennison downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Avery Dennison to Underweight from Neutral with an unchanged price target of $105.
04/18/19
JPMS
04/18/19
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Avery Dennison to Underweight after 26% rally
JPMorgan analyst Jeffrey Zekauskas downgraded Avery Dennison to Underweight from Neutral with an unchanged price target of $105. Avery shares increased 26% year-to-date without improvement in business fundamentals, and "arguably some deterioration," Zekauskas tells investors in a research note. The company's trading multiple is high and business fundamentals seem to be decelerating, says the analyst. He believes "earnings bumps along the way" could negatively impact Avery Dennison's valuation.
BMS acquired by AMCR
$57.94

-0.03 (-0.05%)

08/15/18
RBCM
08/15/18
UPGRADE
RBCM
Sector Perform
Bemis upgraded to Sector Perform from Underperform at RBC Capital
08/15/18
RBCM
08/15/18
UPGRADE
Target $54
RBCM
Sector Perform
Bemis upgraded to Sector Perform at RBC Capital on expected Amcor deal approval
As reported earlier, RBC Capital analyst Arun Viswanathan upgraded Bemis to Sector Perform from Underperform and raised his price target to $54 from $44, saying that while he is cautious about the company's food packaging business, he expects the previously announced acquisition by Amcor to be approved by all parties with minimal divestitures. The analyst further states that the two companies are highly complementary and the combination should yield about $180M in synergies. Viswanathan also likes Berry Global (BERY) and Graphic Packaging Holding (GPK) based on their attractive valuation.
01/31/19
01/31/19
NO CHANGE

Bemis reports Q4 adjusted EPS 71c, consensus 71c
Reports Q4 revenue $1.00B, consensus $990.51M.
04/07/19
BMOC
04/07/19
DOWNGRADE
Target $52
BMOC
Market Perform
Bemis downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Mark Wilde downgraded Bemis (BMS) to Market Perform from Outperform, with a $52 price target, as the Amcor's (AMCRY) purchase of the company is going through the final stages of regulatory review and is scheduled to close on May 15. With Amcor and Bemis's stocks trading close to the acquisition ratio of 5.1 Amcor shares for every share of Bemis, the analyst believes Bemis appears fully valued.
CAG Conagra Brands
$28.49

-0.59 (-2.03%)

03/22/19
GSCO
03/22/19
NO CHANGE
Target $32
GSCO
Buy
Conagra Brands price target raised to $32 at Goldman Sachs after Q3 earnings
Goldman Sachs analyst Jason English nudged his price target on Conagra Brands higher to $32 from $31 and kept his Buy rating after its Q3 earnings beat, even though he sees the "quality" of the results as mixed. The analyst notes that the management succeeded in conveying to investors that earnings estimates "found a support level" while disproving concerns about the company's weakening core business. English further states that the company's unveiling of new Pinnacle Foods initiatives was sooner than he expected and believes that Conagra's earnings visibility has "improved materially", defusing the "uncertainty that lingered" after its Q2 guide-down.
05/14/19
RHCO
05/14/19
INITIATION
Target $35
RHCO
Buy
Conagra Brands initiated with a Buy at SunTrust
SunTrust analyst William Chappell initiated Conagra Brands with a Buy rating and a price target of $35, saying the arrival of new management and its efforts to implement a "scalable, repeatable process" across the organization has led to growth in all of its business units. The analyst also sees signs of stabilization for packaged foods companies generally after a "challenging" few years amid a shift toward more favorable pricing and increased demographic tailwinds for frozen foods as more Millenials have children.
04/11/19
JPMS
04/11/19
NO CHANGE
Target $34
JPMS
Overweight
JPMorgan sees 'much more upside' in Conagra, boosts target to $34
JPMorgan analyst Ken Goldman raised his price target for Conagra Brands to $34 from $30 saying he sees "much more upside" in the shares. The company's longer-term sales guidance seems conservative and beatable, Goldman tells investors in a research note. He also believes management is addressing a number of investor concerns, including the sustainability of the frozen category's strength, the reasons for reductions in A&P spending, and the plan to turn around Pinnacle. Goldman reiterates an Overweight rating on Conagra Brands.
05/20/19
MSCO
05/20/19
INITIATION
Target $31
MSCO
Equal Weight
Conagra Brands resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Pamela Kaufman resumed coverage of Conagra Brands with an Equal Weight rating and $31 price target. While she believes the company is well-positioned for revenue growth ahead of Packaged Food peers, she still sees risk with the turnaround of Pinnacle Foods and thinks the risk-reward appears balanced given recently rising expectations.
FDP Fresh Del Monte
$28.52

-0.73 (-2.50%)

DGII Digi International
$11.88

-0.06 (-0.50%)

09/27/18
LSCM
09/27/18
NO CHANGE
Target $16
LSCM
Buy
Digi International shares can 'work meaningfully higher,' says Lake Street
Lake Street analyst Jaeson Schmidt believes shares of Digi International "can work meaningfully higher from current levels" as investors gain confidence in the ramp of the company's Internet of Things Solutions business and start to better appreciate the potential earnings leverage in the model. After visiting Digi's headquarters, the analyst feels confident that the company "remains on a path of sustained, solid top line growth and improving profitability." He reiterates a Buy rating on Digi International with a $16 price target.
06/20/18
ADAM
06/20/18
NO CHANGE
Target $18
ADAM
Buy
Digi International price target raised to $18 from $15 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Digi International to $18 from $15 following meetings with management. The analyst said the meeting focused on the cold chain monitoring market opportunity and he believes Digi has the team and solution sets to emerge as a leader in the fragmented market. Walkley reiterated his Buy rating on Digi International shares.
07/27/18
LSCM
07/27/18
NO CHANGE
Target $16
LSCM
Buy
Digi International price target raised to $16 from $14 at Lake Street
Lake Street analyst Jaeson Schmidt raised his price target for Digi International to $16 saying the company reported a "solid" quarter and revenue outlook with Internet of Things continuing to ramp. The analyst reiterates a Buy rating on the shares.
07/05/18
FANA
07/05/18
NO CHANGE
Target $16
FANA
Overweight
Digi International target raised to $16 after CFO call at First Analysis
First Analysis analyst David Gearhart raised his price target for Digi International to $16 from $15 following a call with new CFO Gokul Hemmady. The analyst came away with greater confidence that management will execute on its end-to-end solutions strategy and be able to return the core hardware business to "sustained growth while maintaining solid profitability, driving above-market share returns." Gearhart reiterates an Overweight rating on Digi shares.
ECL Ecolab
$181.10

-0.42 (-0.23%)

04/18/19
04/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PepsiCo (PEP) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong citing its "strong" Q1 results that saw organic revenue accelerate to 5% and gross margins top expectations. 2. J.M. Smucker (SJM) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Pamela Kaufman saying she believes the company's reinvestment strategy will drive improved topline momentum across its key segments and should allow the company to return to positive organic growth in FY20. 3. Venator Materials (VNTR) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying he believes that the titanium dioxide "cycle is turning", with destocking activity nearing completion amid improving global demand and pricing. 4. Ecolab (ECL) upgraded to Buy from Neutral at Nomura Instinet with analyst Dan Dolev saying with the problematic energy business soon to be spun-off, Ecolab's "recession resistant qualities should stand out, warranting a significant premium to peers." 5. Qualcomm (QCOM) upgraded to Buy from Hold at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
NOMU
04/18/19
UPGRADE
Target $210
NOMU
Buy
Nomura Instinet upgrades 'recession resistant' Ecolab to Buy from Neutral
Nomura Instinet analyst Dan Dolev upgraded Ecolab to Buy from Neutral and raised his price target for the shares to $210 from $170. With the problematic energy business soon to be spun-off, Ecolab's "recession resistant qualities should stand out, warranting a significant premium to peers," Dolev tells investors in a research note. Following "years of lackluster organic growth, the analyst now expects improved organic revenue growth, better pricing power, a more attractive geographic mix, and enhanced efficiency metrics. UBS this morning downgraded Ecolab to Neutral from Buy.
05/01/19
ADAM
05/01/19
NO CHANGE
Target $198
ADAM
Buy
Ecolab price target raised to $198 from $186 at Canaccord
Canaccord analyst Chip Moore raised his price target for Ecolab to $198 from $186 following the company's Q1 results, saying he finds Ecolab "very well positioned" to benefit from the convergence of population growth, resource volatility and rapid industrialization across the world. The company's recurring services model drives high visibility, even in a variable macro environment, Moore contends. He maintains a Buy rating.
04/18/19
UBSW
04/18/19
DOWNGRADE
Target $186
UBSW
Neutral
Ecolab downgraded to Neutral from Buy at UBS
UBS analyst John Roberts downgraded Ecolab to Neutral from Buy while raising his price target for the shares to $186 from $180. The analyst cites valuation for the downgrade. Nomura Instinet this morning upgraded Ecolab to Buy.
FDC First Data
$25.87

-0.13 (-0.50%)

04/30/19
KEYB
04/30/19
NO CHANGE
Target $155
KEYB
Overweight
Global Payments price target raised to $155 from $135 at KeyBanc
KeyBanc analyst Josh Beck raised his price target for Global Payments (GPN) to $155 from $135 ahead of quarterly results as he expects best-in-class organic growth in the HSD to LDD within the U.S. direct channel. An early strategic pivot toward software followed by recent M&A moves suggest the 2020 target of 60% tech-led distribution is likely to provide insulation against potential consolidation headwinds tied to Fiserv (FISV)-First Data (FDC) and FISWP mergers, he contends. Beck reiterates an Overweight rating on the shares.
04/30/19
BARD
04/30/19
NO CHANGE
BARD
FIS deal clearance positive for Fiserv-First Data, says Baird
Baird analyst says David Koning said he views the fact that the FTC granted early HSR termination to FIS (FIS) and Worldpay (WP) as good news since it means no second request is coming from the DOJ. He noted that Fiserv (FISV) has already announced that it got a second DOJ request, but he said the business unit concentrations for Fiserv and First Data (FDC) "aren't that dramatically different" and he views the clearing granted to FIS as good news for Fiserv-First Data as well.
04/03/19
SPHN
04/03/19
NO CHANGE
SPHN
Fiserv named a Best Idea at Stephens
Stephens analyst Brett Huff named Fiserv (FISV) as his Best Idea, replacing Global Payments (GPN), stating that he thinks 40% accretion from Fiserv's deal for First Data (FDC) is "very doable" even with his conservative assumptions. While telling investors that he still "really likes" Global Payments, Huff said he thinks Fiserv is "more mispriced." After updating his estimates for his accretion model, the analyst raised his price target on Fiserv shares to $110 from $95 and keeps an Overweight rating on the shares.
05/06/19
BARD
05/06/19
NO CHANGE
Target $106
BARD
Outperform
Fiserv named a new 'Fresh Pick' at Baird
Baird analyst David Koning assigned a "Fresh Pick" designation to Fiserv (FISV) after First Data's (FDC) Global Business Solutions, or GBS, segment accelerated to +10% organic growth, which Koning noted was the best growth of the merchant acquirers in Q1. The analyst, who thinks results from both Fiserv and First Data "deserved a better reaction," also noted that Fiserv has underperformed the S&P since the end of January and thinks relief rallies may be coming. Koning has an Outperform rating and $106 price target on Fiserv shares.
HRL Hormel Foods
$39.71

-0.05 (-0.13%)

04/23/19
GSCO
04/23/19
DOWNGRADE
Target $35
GSCO
Sell
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Adam Samuelson downgraded Hormel Foods to Sell from Neutral and lowered his price target for the shares to $35 from $37. African swine fever is upending the protein markets, Samuelson tells investors in a research note. JPMorgan this morning also downgraded Hormel Foods to a sell-equivalent rating.
04/23/19
04/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hormel Foods (HRL) downgraded to Sell from Neutral at Goldman Sachs and to Underweight from Neutral at JPMorgan. 2. Digital Realty (DLR) downgraded to Hold from Buy at Jefferies with analyst Jonathan Petersen saying market absorption numbers from datacenterHawk suggest a leasing quarter even worse than Q4 of 2018 for the data center real estate investment trusts. 3. PSEG (PEG) downgraded to Neutral from Overweight at JPMorgan with analyst Christopher Turnure saying now that zero emission credits have been formally awarded, the he expects PJM capacity market reform driven-uncertainty to continue near-term or longer if the Federal Energy Regulatory Commission fails to approve a revised methodology soon. He sees limited near-term upside in PSEG shares. 4. Fortis (FTS) downgraded to Market Perform from Outperform at Raymond James. 5. Crocs (CROX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Erinn Murphy saying the "runway for significant share appreciation becomes more difficult from here." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/19
JPMS
04/23/19
DOWNGRADE
Target $36
JPMS
Underweight
JPMorgan downgrades Hormel Foods to Underweight on rising pork costs
JPMorgan analyst Thomas Palmer downgraded Hormel Foods to Underweight from Neutral and lowered his price target for the shares to $36 from $40. Goldman Sachs this morning also downgraded the shares. Rising pork costs and worsening Jennie-O ground turkey brand distribution points could weigh on Hormel's earnings, Palmer tells investors in a research note. Hormel is heavily reliant upon pork as an input for its products, and the company will likely be able to fully offset these cost increases through pricing, Palmer tells investors in a research note. African swine fever in China could result in an extended period of elevated pork pricing in the U.S., he contends.
04/23/19
GSCO
04/23/19
DOWNGRADE
GSCO
Sell
Goldman downgrades Hormel to Sell, upgrades Sanderson to Neutral
Goldman Sachs analyst Adam Samuelson downgraded Hormel Foods (HRL) to Sell from Neutral and cut his price target for the shares to $35 from $37. With his estimates now below consensus and "limited" earnings growth forecasted through fiscal 2020, the analyst sees risk to Hormel's "premium" valuation. The breadth and depth of African swine fever's impact across the Chinese pork industry, and as a result the global protein industry, will be significant in the near-to-medium-term, Samuelson tells investors in a research note. Buy-rated Tyson Foods (TSN) and BRF S.A. (BRFS) remain the analyst's preferred way to gain exposure to the Global Protein market. Samuelson this morning also upgraded Sanderson Farms (SAFM) to Neutral from Sell and raised his price target for the shares for $131 from $81. Higher competing protein prices and improving U.S. export prospects "make a more negative stance unsustainable," Samuelson contends. He raised his fiscal 2020 and 2021 margin forecasts for the company to "normalized levels." However, further upside is tempered, for now, by increases in U.S. processing capacity coming on stream over the next 18 months, the analyst contends.
LCUT Lifetime Brands
$9.20

-0.38 (-3.97%)

MA MasterCard
$253.54

1.06 (0.42%)

04/16/19
SPHN
04/16/19
NO CHANGE
SPHN
MasterCard deal for Vyze may be positive for Curo, Rent-A-Center, says Stephens
Stephens analyst Vincent Caintic said Mastercard's (MA) acquisition of Vyze, which provides a platform that links retailers with lenders, is a potential positive for Curo Group (CURO) and Rent-A-Center (RCII), whose "Zibby" and AcceptanceNow are part of the Vyze network. The tie-in with Mastercard may provide more loan and lease application flow to both Zibby and AcceptanceNow, said the analyst. Caintic views the news as more mixed for Alliance Data (ADS), stating that he expects Mastercard's relationship to result in more application flow to Vyze partners, but this may take away from flow to Alliance's cards and lessens the importance of the private label platform.
04/15/19
PIPR
04/15/19
NO CHANGE
PIPR
Piper says FinTech secular drives 'remain strong' into Q1 results
While absolute and relative valuations in FinTech are back near the all-time highs, the Federal Reserve "has moved from a headwind last Fall to a Neutral factor for economic growth and equity valuations," Piper Jaffray analyst Jason Deleeuw tells investors in a research note. Also, the ongoing secular drivers for FinTech "remain strong" as global payments and business ecosystems digitize, says the analyst. He remains constructive on FinTech names heading into Q1 earnings and also tells investors to look at some mortgage/real estate services stocks. Deleeuw's top ideas are Black Knight (BKI), Redfin (RDFN), Euronet (EEFT) and Cannae Holdings (CNNE). He also boosted his price target for Overweight-rated Euronet to $171 from $159, for Overweight-rated Global Payments (GPN) to $163 from $152, for Overweight-rated MasterCard (MA) to $272 from $262, for Neutral-rated PayPal (PYPL) to $104 from $97, for Overweight-rated Visa (V) to $191 from $178 and for Neutral-rated Worldpay (WP) to $115 from $101.
05/03/19
KEYB
05/03/19
NO CHANGE
Target $265
KEYB
Overweight
MasterCard price target raised to $265 from $230 at KeyBanc
KeyBanc analyst Josh Beck raised his price target for MasterCard to $265 from $230 and maintained an Overweight rating, saying assessments and incentives drove the top line above the Street's Q1 print, whiletransaction processing fees and other revenue was lower as EPS beats. Vocalink initiatives in an expanding set of countries that now includes the Phillipines and Saudi Arabia is opening up opportunities beyond the core card market, Beck tells investors in a research note, which he thinks warrants a higher multiple.
04/23/19
MSCO
04/23/19
NO CHANGE
MSCO
Overweight
Visa, MasterCard price targets raised ahead of earnings at Morgan Stanley
Morgan Stanley analyst James Faucette said his data tracker suggests slightly weaker consumer spending this quarter, particularly in international markets, indicating some deceleration in payment trends in the March quarter for Visa (V) and MasterCard (MA). However, he believes this "noise" is already reflected in Street estimates and he believes the benefits the companies are seeing from improving computing power, greater scale, secular growth drivers and "relatively resilient" consumer spending trends should persist. Ahead of the card processors' earnings reports, Faucette raised his price target on Visa to $173 from $165 and on MasterCard to $259 from $250 and he keeps Overweight ratings on both stocks.

TODAY'S FREE FLY STORIES

SBH

Sally Beauty

$12.30

-2.49 (-16.84%)

, AMZN

Amazon.com

$1,913.43

3.01 (0.16%)

07:35
06/25/19
06/25
07:35
06/25/19
07:35
Recommendations
Sally Beauty, Amazon.com analyst commentary  »

Sally Beauty price target…

SBH

Sally Beauty

$12.30

-2.49 (-16.84%)

AMZN

Amazon.com

$1,913.43

3.01 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

FB

Facebook

$192.56

1.4 (0.73%)

, CZR

Caesars

$11.43

1.44 (14.41%)

07:35
06/25/19
06/25
07:35
06/25/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

FB

Facebook

$192.56

1.4 (0.73%)

CZR

Caesars

$11.43

1.44 (14.41%)

D

Dominion

$79.22

0.88 (1.12%)

MNK

Mallinckrodt

$8.42

-0.54 (-6.03%)

NCLH

Norwegian Cruise Line

$50.84

-0.29 (-0.57%)

KPTI

Karyopharm

$6.35

-0.085 (-1.32%)

LAUR

Laureate Education

$15.00

-0.365 (-2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 02

    Jul

  • 06

    Jul

  • 10

    Jul

  • 16

    Jul

PCRX

Pacira

$43.14

-0.82 (-1.87%)

07:34
06/25/19
06/25
07:34
06/25/19
07:34
Hot Stocks
Pacira announces EMA validation for Exparel MAA »

Pacira announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLYA

Playa Hotels & Resorts

$7.40

-0.33 (-4.27%)

07:34
06/25/19
06/25
07:34
06/25/19
07:34
Recommendations
Playa Hotels & Resorts analyst commentary  »

Deutsche Bank closes out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

07:33
06/25/19
06/25
07:33
06/25/19
07:33
Conference/Events
Aldeyra to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

$0.85

-0.0563 (-6.22%)

07:31
06/25/19
06/25
07:31
06/25/19
07:31
Hot Stocks
BioPharmX announces results from Phase 2b clinical trial of BPX-041 »

BioPharmX announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

MEET

Meet Group

$3.31

-0.265 (-7.42%)

, AAPL

Apple

$198.60

-0.17 (-0.09%)

07:31
06/25/19
06/25
07:31
06/25/19
07:31
Recommendations
Meet Group, Apple, Alphabet, Alphabet Class A analyst commentary  »

Meet Group should be able…

MEET

Meet Group

$3.31

-0.265 (-7.42%)

AAPL

Apple

$198.60

-0.17 (-0.09%)

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

AKRX

Akorn

$4.71

-0.06 (-1.26%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Akorn »

Akorn trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ETFC

E-Trade

$44.57

-1.66 (-3.59%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Aldeyra 

Aldeyra trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.51

-0.98 (-3.11%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Periodicals
Buffett denies reports of tension between him, 3G over Kraft Heinz, CNBC reports »

Buffett says 3G's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$223.66

1.76 (0.79%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Recommendations
Tesla analyst commentary  »

Oppenheimer continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$72.05

0.91 (1.28%)

, MCD

McDonald's

$203.92

-0.29 (-0.14%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Upgrade
GrubHub, McDonald's, Starbucks rating change  »

Citi sees five reasons to…

GRUB

GrubHub

$72.05

0.91 (1.28%)

MCD

McDonald's

$203.92

-0.29 (-0.14%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 26

    Jul

ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

07:25
06/25/19
06/25
07:25
06/25/19
07:25
Conference/Events
Eldorado Resorts to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BPOP

Popular

$52.70

0.37 (0.71%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Recommendations
Popular analyst commentary  »

Popular's valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MYGN

Myriad Genetics

$23.04

-0.47 (-2.00%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Hot Stocks
Myriad Genetics announces publication of EndoPredict cost effectiveness study »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 06

    Aug

  • 13

    Nov

HEXO

HEXO Corp

$5.35

-0.245 (-4.38%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Downgrade
HEXO Corp rating change  »

HEXO Corp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXL

Anavex

$3.25

-0.12 (-3.56%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Hot Stocks
Anavex announces first patient dosed in Rett syndrome extension study »

Anavex announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$14.38

-0.21 (-1.44%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Recommendations
Angi Homeservices analyst commentary  »

Angi Homeservices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BHF

Brighthouse Financial

$38.10

-0.01 (-0.03%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Downgrade
Brighthouse Financial rating change  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

, AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

07:18
06/25/19
06/25
07:18
06/25/19
07:18
Hot Stocks
Applied Genetic names Theresa Heah CMO, Brian Krex general counsel »

Applied Genetic (AGTC)…

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

ALXN

Alexion

$126.92

-5.55 (-4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

MCHP

Microchip

$85.16

0.08 (0.09%)

07:16
06/25/19
06/25
07:16
06/25/19
07:16
Initiation
Microchip initiated  »

Microchip initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$96.26

-0.41 (-0.42%)

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Upgrade
Lincoln National rating change  »

Lincoln National upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.